کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1922835 1535843 2016 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability
ترجمه فارسی عنوان
سیلدنافیل علائم استرس اکسیداتیو در پرفشاری خون شریانی ریه را کاهش می دهد: ارزیابی با ترکیب اسید چرب، سطح هیدروکسیوننن و تغییرات ضربان قلب
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی سالمندی
چکیده انگلیسی


• Sildenafil showed antioxidant and anti-inflammatory effects in pulmonary hypertension.
• Sildenafil reduced hydroxynonenal level and improved fatty acid profile in serum.
• Improvement of heart rate variability and functional capacity was noted after therapy.
• Mild prooxidant activity is suggested as the mechanism to improve sildenafil efficacy.

Pulmonary arterial hypertension (PAH) is a rare multifactorial disease with an unfavorable prognosis. Sildenafil therapy can improve functional capacity and pulmonary hemodynamics in PAH patients. Nowadays, it is increasingly recognized that the effects of sildenafil are pleiotropic and may also involve changes of the pro-/antioxidant balance, lipid peroxidation and autonomic control. In present study we aimed to assess the effects of sildenafil on the fatty acids (FAs) status, level of hydroxynonenal (HNE) and heart rate variability (HRV) in PAH patients. Patients with PAH were characterized by an increase in HNE and changes in the FAs composition with elevation of linoleic, oleic, docosahexanoic acids in phospholipids as well as reduced HRV with sympathetic predominance. Sildenafil therapy improved exercise capacity and pulmonary hemodynamics and reduced NT-proBNP level in PAH. Antioxidant and anti-inflammatory effects of sildenafil were noted from the significant lowering of HNE level and reduction of the phopholipid derived oleic, linoleic, docosahexanoic, docosapentanoic FAs. That was also associated with some improvement of HRV on account of the activation of the neurohumoral regulatory component. Incomplete recovery of the functional metabolic disorders in PAH patients may be assumed from the persistent increase in free FAs, reduced HRV with the sympathetic predominance in the spectral structure after treatment comparing to control group. The possibilities to improve PAH treatment efficacy through mild stimulation of free radical reactions and formation of hormetic reaction in the context of improved NO signaling are discussed.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Redox Biology - Volume 7, April 2016, Pages 48–57
نویسندگان
, , , , , , ,